Organization · Venture Studio
VIC Tech
VIC Tech is a private technology venture development firm that focuses on forming new technology companies, providing business development support, and offering management services to its portfolio companies.
Overview
What VIC Tech does
What VIC Tech is
VIC Tech is a private technology venture development firm that focuses on forming new technology companies, providing business development support, and offering management services to its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 6, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find VIC Tech elsewhere
Open the official website or a supported primary organization account.
Capability profile
VIC Tech as a funder
Investment thesis
VIC Tech focuses on creating and developing high-impact life science companies based on technologies licensed from top research institutions. The organization aims to commercialize selected technologies with significant societal impacts.
Focus narrative
VIC Tech invests in life science technologies and has established a venture development ecosystem to address the commercialization challenges these technologies face. Each new portfolio company receives seed investments ranging from $250,000 to $500,000, allowing them to navigate the complexities of bringing innovative solutions to market. The organization screens approximately 1,500 technologies annually to identify those with strong intellectual property foundations and significant commercial opportunities.
Value beyond capital
VIC Tech provides significant value to its portfolio companies through seed funding, access to a robust network of co-investors, and a comprehensive venture development ecosystem that supports commercialization efforts. The organization emphasizes strong intellectual property and societal impact, ensuring that each venture is well-positioned for success.
Terms and economics
- Typical check
- $250,000–$500,000
Focus and fit
- Stages
- Seed
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Akeso Biomedical, Inc. developing compounds to fight bacterial infections; BiologicsMD™ focused on therapies for hair loss; Calyxo with a kidney stone retrieval device; CardioWise improving cardiac health monitoring; Cellia Science, Inc. for rapid blood cell assays; Enhance Health for chronic disease monitoring; Filtravate with bio-filtration membranes; icosiMED for fat loss therapy; i-Seq Biotechnology for vaccines; Neurexis Therapeutics preventing brain damage; and Nob Hill Therapeutics, Inc. creating a nebulizer for respiratory diseases.
Capability profile
VIC Tech as a program host
Program thesis
VIC Tech is dedicated to creating and developing high-impact life science companies based on technologies licensed from top research institutions worldwide.
Focus narrative
VIC Tech invests in life science technologies and has developed a venture development ecosystem to navigate commercialization challenges. Each new portfolio company receives seed investments ranging from $250,000 to $500,000 from the VIC Investor Network, with a rigorous screening process for approximately 1,500 technologies annually.
Value and support
Founders receive seed investments, access to a robust venture development ecosystem, and support in navigating commercialization challenges for their technologies.
Terms and economics
- Indicative investment
- $250,000
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- United States
Alumni and track record
Alumni context
Notable portfolio companies include Akeso Biomedical, BiologicsMD™, Calyxo, CardioWise, Cellia Science, Enhance Health, Filtravate, icosiMED, i-Seq Biotechnology, Neurexis Therapeutics, and Nob Hill Therapeutics, each focusing on innovative solutions in life sciences.
Common questions
What to know about VIC Tech
Upseed classifies VIC Tech under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.